- 2015 IMAX Global Box Office reaches $1 billion, a 31% increase over 2014, and significantly surpasses worldwide industry box office growth of approximately 10%
- 2015 Adjusted EBITDA grew 30% year-over-year to $140.8 million, resulting in adjusted EBITDA margins of 40.5%, up from 38.3% in the year-ago period
- 2015 adjusted EPS of $1.02 grew 36%, driven by strong box office growth and network installations that were partially offset by FX and investments in new ventures
- IMAX saw sizeable installations growth in 2015 – with 136 new installations up from 113 in 2014
- IMAX raises installation guidance for 2016 from 115-120 range to 135-140 range, consistent with elevated levels seen in 2015
- IMAX successfully listed shares of IMAX China (HKSE: 1970) on the Hong Kong Stock Exchange at HKD$31 on Oct. 8, 2015, and has seen its share price increase 45% through Feb. 24, 2016
NEW YORK, Feb. 24, 2016 /PRNewswire/ -- IMAX Corporation (NYSE: IMAX) today reported results for the fourth quarter and full year 2015, including its highest-ever quarter in revenue and among the highest-ever quarters for adjusted EBITDA and adjusted net earnings per diluted share ("EPS") in the Company's history.
"2015 was undoubtedly a historic year for IMAX – we delivered a record $1 billion in global box office, added 136 theatres to our network to bring our global total to over 1000 screens, launched our highly anticipated laser projection system, and of course, successfully listed our China business on the Hong Kong Stock Exchange," said IMAX CEO Richard L. Gelfond. "IMAX is clearly benefiting from a global trend in the film industry to make more big-budget blockbuster movies. And with so many major movie franchises releasing important sequels in 2016 and 2017, we believe we're extremely well positioned for success in the years ahead."
Fourth-Quarter 2015 Results
The Company reported revenues of $119.3 million, up 16.5% from the year-ago period. Adjusted EBITDA, as calculated in accordance with the Company's credit facility, grew 5.8% to $48.1 million. Adjusted net income after non-controlling interest of $27.3 million grew 12.6%. Adjusted diluted earnings per share of $0.39 also grew 14.7%. Reported net income after non-controlling interest was $22.5 million, or $0.32 per diluted share. For reconciliations of adjusted net income to reported net income and for the definition of adjusted EBITDA and free cash flow, please see the tables at the end of this press release. The Company also reported a fourth-quarter global per-screen average of $318,600, up 9% over the year-ago period.
Full-Year 2015 Results
Full-year 2015 revenues of $373.8 million grew 28.7%. Adjusted EBITDA, as calculated in accordance with the Company's credit facility, rose 29.8% to $140.8 million. Adjusted net income of $73.0 million grew 39.0% and adjusted net earnings per diluted share of $1.02 grew 36.0%. Reported net income attributable to common shareholders was $55.8 million, or $0.78 per diluted share. The Company also reported a global 2015 per-screen average of $1,155,800, up 13.2% from the prior year.
The full-year installation total grew to 154 theatre systems, of which 18 were upgrades, compared with 121 and eight, respectively, in the prior-year period. The total IMAX® theatre network consisted of 1,061 systems as of Dec. 31, 2015, of which 943 were in commercial multiplexes. IMAX signed contracts for 138 theatres in 2015, across 24 countries, resulting in 372 theatre systems in backlog as of Dec. 31, 2015, compared to 397 theatre systems in backlog as of Dec. 31, 2014. The Company's top three markets for signings were China, the United States and Japan. For a breakdown of theatre system signings, installations, network and backlog by type, please see the end of this press release.
"As we look to 2016, we are very encouraged by what we see in the marketplace regarding our network expansion opportunities not only in China, but in other strategically important markets such as Japan, the Middle East and continental Europe," said Mr. Gelfond. "With more than 1,000 theatres in our global network, $1 billion in box office running through our screens, and more than $300 million in cash and virtually no debt, we believe we have significant opportunities to take our Company to the next level."
Conference Call
The Company will host a conference call on Feb. 24 at 4:30pm ET to discuss its fourth-quarter and full-year 2015 results. To access the call via telephone, interested parties in the US and Canada should dial (800) 505-9568 approximately 5 to 10 minutes before the call begins. International callers should dial (416) 204-9271. The conference ID for the call is 4081404. A replay of the call will be available via webcast on the 'Investor Relations' section of www.imax.com or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 4081404.
About IMAX Corporation
IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX theatres to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe.
IMAX is headquartered in New York, Toronto and Los Angeles, with offices in London, Tokyo, Shanghai and Beijing. As of Dec. 31, 2015, there were 1,061 IMAX theatres (943 commercial multiplexes, 19 commercial destinations and 99 institutions) in 67 countries. On Oct. 8, 2015, shares of IMAX China, a subsidiary of IMAX Corp., began trading on the Hong Kong Stock Exchange under the stock code "HK.1970."
IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, IMAX Is Believing® and IMAX nXos® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).
This press release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, references to future capital expenditures (including the amount and nature thereof), business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, plans and references to the future success of IMAX Corporation together with its wholly-owned subsidiaries (the "Company") and expectations regarding the Company's future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to , the signing of theatre system agreements; conditions, changes and developments in the commercial exhibition industry; the performance of IMAX DMR films; the potential impact of increased competition in the markets within which the Company operates; competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company's growth and operations in China; the Company's largest customer accounting for a significant portion of the Company's revenue and backlog; risks related to new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security; risks related to the Company's inability to protect the Company's intellectual property; risks related to the Company's implementation of a new enterprise resource planning system; general economic, market or business conditions; the failure to convert theatre system backlog into revenue; changes in laws or regulations; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX's most recent Annual Report on Form 10-K.
For additional information please contact:
| Investors: IMAX Corporation, New York Jessica Kourakos 212-821-0100
Business Media: Sloane & Company, New York Whit Clay 212-446-1864
|
Media: IMAX Corporation, New York Ann Sommerlath 212-821-0155
Entertainment Media: Principal Communications Group, Los Angeles Melissa Zuckerman/Paul Pflug 323-658-1555 |
Additional Information
| Signings and Installations |
||||||
| December 31, 2015 |
||||||
| Twelve Months |
||||||
| Ended December 31, |
||||||
| Theater Signings: |
2015 |
2014 |
||||
| Full new sales and sales-type lease arrangements |
55 |
(1) |
81 |
(1) |
||
| New joint revenue sharing arrangements |
78 |
23 |
||||
| Total new theaters |
133 |
104 |
||||
| Upgrades of IMAX theater systems |
5 |
(2)(3) |
14 |
(2)(3) |
||
| Total Theater Signings |
138 |
118 |
||||
| Twelve Months |
||||||
| Ended December 31, |
||||||
| Theater Installations: |
2015 |
2014 |
||||
| Full new sales and sales-type lease arrangements |
56 |
46 |
||||
| New joint revenue sharing arrangements |
80 |
67 |
||||
| Total new theaters |
136 |
113 |
||||
| Upgrades of IMAX theater systems |
18 |
(4)(5) |
8 |
(4) |
||
| Total Theater Installations |
154 |
121 |
||||
| As of December 31, |
||||||
| Theater Backlog: |
2015 |
2014 |
||||
| New sales and sales-type lease arrangements |
145 |
153 |
||||
| New joint revenue sharing arrangements |
212 |
217 |
||||
| Total new theaters |
357 |
370 |
||||
| Upgrades of IMAX theater systems |
15 |
27 |
||||
| Total Theaters in Backlog |
372 |
(6)(7) |
397 |
(6)(8) |
||
| As of December 31, |
||||||
| Theater Network: |
2015 |
2014 |
||||
| Commercial Multiplex Theaters: |
||||||
| Sales and sales-type lease arrangements |
414 |
358 |
||||
| Joint revenue sharing arrangements |
529 |
451 |
||||
| Total Commercial Multiplex Theaters |
943 |
809 |
||||
| Commercial Destination Theaters |
19 |
19 |
||||
| Institutional Theaters |
99 |
106 |
||||
| Total IMAX Theater Network |
1,061 |
934 |
||||
______________________
| (1) |
Includes four signings which replaced theatres under an existing arrangement in backlog (2014 – four signings). |
| (2) |
Includes three signings for the installation of laser-based digital systems under sales and sales-type lease arrangements in existing theatre locations (2014 – five signings). |
| (3) |
Includes two signings for the installation of an upgrade to a xenon-based digital system under sales and sales-type lease arrangements (2014 – three signings under sales and sales-type lease arrangements, three signings under short-term operating lease arrangements and three signings under joint revenue sharing arrangements). |
| (4) |
Includes two installations of an upgrade to a xenon-based digital system, one of which is under a sales and sales-type lease arrangement and another under a short-term operating lease arrangement (2014 – three under sales and sales-type lease arrangements, two under short-term lease arrangement, one under an operating lease arrangement and two under joint revenue sharing arrangement). |
| (5) |
Includes 16 installations of an upgrade to a laser-based digital system (10 under sales and sales-type lease arrangements, one under an operating lease arrangement and five under joint revenue sharing arrangements) |
| (6) |
Includes 24 laser-based digital theatre system configurations (2014 – 71), including upgrades. The Company continues to develop and roll out its laser-based digital projection system. See "Research and Development" in this Part I for additional information. |
| (7) |
Includes 15 upgrades to a digital theatre system, in existing IMAX theatre locations (2 xenon and 13 laser). |
| (8) |
Includes 27 upgrades to a digital theatre system, in existing IMAX theatre locations (2 xenon and 25 laser, of which 4 are under joint revenue sharing arrangements). |
Additional Information (continued)
2015 DMR Films:
In 2015, 44 films were converted through the IMAX DMR process and released to theatres in the IMAX network by film studios as compared to 40 films in 2014. These films were:
2016 DMR Films:
To date, the Company has announced the following 26 DMR titles to be released in 2016 to the IMAX theatre network. The Company remains in active negotiations with all of the major Hollywood studios for additional films to fill out its short and long-term film slate, and anticipates that a similar number of IMAX DMR titles will be released to the IMAX theatre network in 2016 to the films that were released to the IMAX theatre network in 2015.
| IMAX CORPORATION |
|||||||||||||
| CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||||||||
| In accordance with United States Generally Accepted Accounting Principles |
|||||||||||||
| (In thousands of U.S. dollars, except per share amounts) |
|||||||||||||
| Three Months |
Years Ended |
||||||||||||
| Ended December 31, |
Ended December 31, |
||||||||||||
| 2015 |
2014 |
2015 |
2014 |
||||||||||
| Revenues |
|||||||||||||
| Equipment and product sales |
$ |
46,113 |
$ |
41,084 |
$ |
118,937 |
$ |
78,705 |
|||||
| Services |
46,266 |
40,794 |
161,964 |
142,607 |
|||||||||
| Rentals |
24,645 |
18,427 |
83,651 |
60,705 |
|||||||||
| Finance income |
2,309 |
2,152 |
9,112 |
8,524 |
|||||||||
| Other |
- |
- |
141 |
- |
|||||||||
| 119,333 |
102,457 |
373,805 |
290,541 |
||||||||||
| Costs and expenses applicable to revenues |
|||||||||||||
| Equipment and product sales |
20,625 |
17,871 |
63,635 |
36,997 |
|||||||||
| Services |
20,654 |
15,910 |
70,855 |
62,228 |
|||||||||
| Rentals |
6,171 |
4,932 |
20,027 |
17,928 |
|||||||||
| 47,450 |
38,713 |
154,517 |
117,153 |
||||||||||
| Gross margin |
71,883 |
63,744 |
219,288 |
173,388 |
|||||||||
| Selling, general and administrative expenses |
32,997 |
24,937 |
115,345 |
93,260 |
|||||||||
| (including share-based compensation expense of $7.0 million and $21.9 million for the three months and year ended December 31, 2015, respectively (2014 - expense of $3.8 million and $15.1 million, respectively)) |
|||||||||||||
| Research and development |
3,119 |
4,628 |
12,730 |
16,096 |
|||||||||
| Amortization of intangibles |
558 |
465 |
1,860 |
1,724 |
|||||||||
| Receivable provisions, net of recoveries |
43 |
276 |
752 |
918 |
|||||||||
| Asset impairments |
160 |
314 |
405 |
314 |
|||||||||
| Impairment of investments |
75 |
2,556 |
425 |
3,206 |
|||||||||
| Income from operations |
34,931 |
30,568 |
87,771 |
57,870 |
|||||||||
| Interest income |
241 |
216 |
968 |
405 |
|||||||||
| Interest expense |
(491) |
(121) |
(1,661) |
(924) |
|||||||||
| Income from operations before income taxes |
34,681 |
30,663 |
87,078 |
57,351 |
|||||||||
| Provision for income taxes |
(7,644) |
(7,799) |
(20,052) |
(14,466) |
|||||||||
| Loss from equity-accounted investments, net of tax |
(792) |
(350) |
(2,402) |
(1,071) |
|||||||||
| Income from continuing operations |
26,245 |
22,514 |
64,624 |
41,814 |
|||||||||
| Income from discontinued operations, net of tax |
- |
- |
- |
355 |
|||||||||
| Net income |
26,245 |
22,514 |
64,624 |
42,169 |
|||||||||
| Less: net income attributable to non-controlling interests |
(3,752) |
(1,522) |
(8,780) |
(2,433) |
|||||||||
| Net income attributable to common shareholders |
$ |
22,493 |
$ |
20,992 |
$ |
55,844 |
$ |
39,736 |
|||||
| Net income per share attributable to common shareholders - Basic: |
|||||||||||||
| Net income per share from continuing operations |
$ |
0.33 |
$ |
0.30 |
$ |
0.79 |
$ |
0.57 |
|||||
| Net income per share from discontinued operations |
- |
- |
- |
0.01 |
|||||||||
| $ |
0.33 |
$ |
0.30 |
$ |
0.79 |
$ |
0.58 |
||||||
| Net income per share attributable to common shareholders - Diluted: |
|||||||||||||
| Net income per share from continuing operations |
$ |
0.32 |
$ |
0.30 |
$ |
0.78 |
$ |
0.56 |
|||||
| Net income per share from discontinued operations |
- |
- |
- |
- |
|||||||||
| $ |
0.32 |
$ |
0.30 |
$ |
0.78 |
$ |
0.56 |
||||||
| Weighted average number of shares outstanding (000's): |
|||||||||||||
| Basic |
69,364 |
68,769 |
69,526 |
68,346 |
|||||||||
| Fully Diluted |
70,764 |
69,958 |
71,058 |
69,754 |
|||||||||
| Additional Disclosure: |
|||||||||||||
| Depreciation and amortization(1) |
$ |
11,612 |
$ |
9,819 |
$ |
42,803 |
$ |
33,756 |
|||||
| (1) Includes $0.4 million and $1.0 million of amortization of deferred financing costs charged to interest expense for the three months and year ended December 31, 2015 (2014 - $0.1 million and $0.5 million, respectively). |
|||||||||||||
| IMAX CORPORATION |
|||||
| CONSOLIDATED BALANCE SHEETS |
|||||
| In accordance with United States Generally Accepted Accounting Principles |
|||||
| (In thousands of U.S. dollars) |
|||||
| As at December 31, |
|||||
| 2015 |
2014 |
||||
| Assets |
|||||
| Cash and cash equivalents |
$ |
317,449 |
$ |
106,503 |
|
| Accounts receivable, net of allowance for doubtful accounts of $1,146 (December 31, 2014 — $947) |
97,981 |
76,051 |
|||
| Financing receivables |
117,231 |
105,700 |
|||
| Inventories |
38,753 |
17,063 |
|||
| Prepaid expenses |
6,498 |
4,946 |
|||
| Film assets |
14,571 |
15,163 |
|||
| Property, plant and equipment |
218,267 |
183,424 |
|||
| Other assets |
26,527 |
23,047 |
|||
| Deferred income taxes |
25,766 |
23,058 |
|||
| Other intangible assets |
28,950 |
27,551 |
|||
| Goodwill |
39,027 |
39,027 |
|||
| Total assets |
$ |
931,020 |
$ |
621,533 |
|
| Liabilities |
|||||
| Bank indebtedness |
$ |
29,667 |
$ |
4,710 |
|
| Accounts payable |
23,455 |
26,145 |
|||
| Accrued and other liabilities |
95,748 |
75,425 |
|||
| Deferred revenue |
104,993 |
88,566 |
|||
| Total liabilities |
253,863 |
194,846 |
|||
| Commitments and contingencies |
|||||
| Non-controlling interests |
3,307 |
43,912 |
|||
| Shareholders' equity |
|||||
| Capital stock common shares — no par value. Authorized — unlimited number. |
|||||
| Issued and outstanding — 69,673,244 (December 31, 2014 — 68,988,050) |
448,310 |
344,862 |
|||
| Other equity |
163,094 |
47,319 |
|||
| Accumulated earnings (deficit) |
19,930 |
(6,259) |
|||
| Accumulated other comprehensive loss |
(7,443) |
(3,147) |
|||
| Total shareholders' equity attributable to common shareholders |
623,891 |
382,775 |
|||
| Non-controlling interests |
49,959 |
- |
|||
| Total shareholders' equity |
673,850 |
382,775 |
|||
| Total liabilities and shareholders' equity |
$ |
931,020 |
$ |
621,533 |
|
| IMAX CORPORATION |
||||||||
| CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||||
| In accordance with United States Generally Accepted Accounting Principles |
||||||||
| (In thousands of U.S. dollars) |
||||||||
| Years Ended December 31, |
||||||||
| 2015 |
2014 |
|||||||
| Cash provided by (used in): |
||||||||
| Operating Activities |
||||||||
| Net income |
$ |
64,624 |
$ |
42,169 |
||||
| Income from discontinued operations, net of tax |
- |
(355) |
||||||
| Adjustments to reconcile net income to cash from operations: |
||||||||
| Depreciation and amortization |
42,803 |
33,756 |
||||||
| Write-downs, net of recoveries |
3,725 |
5,294 |
||||||
| Change in deferred income taxes |
(1,336) |
627 |
||||||
| Stock and other non-cash compensation |
22,379 |
15,467 |
||||||
| Unrealized foreign currency exchange loss |
785 |
1,180 |
||||||
| Loss from equity-accounted investments |
3,838 |
1,774 |
||||||
| Gain on non-cash contribution to equity-accounted investees |
(1,436) |
(703) |
||||||
| Investment in film assets |
(15,119) |
(19,233) |
||||||
| Changes in other non-cash operating assets and liabilities |
(36,578) |
6,057 |
||||||
| Net cash provided by operating activities from discontinued operations |
- |
572 |
||||||
| Net cash provided by operating activities |
83,685 |
86,605 |
||||||
| Investing Activities |
||||||||
| Purchase of property, plant and equipment |
(43,257) |
(40,104) |
||||||
| Investment in joint revenue sharing equipment |
(28,474) |
(16,838) |
||||||
| Investment in new business ventures |
(2,000) |
(2,500) |
||||||
| Proceeds from sale of business venture |
- |
507 |
||||||
| Acquisition of other intangible assets |
(5,065) |
(2,918) |
||||||
| Net cash used in investing activities |
(78,796) |
(61,853) |
||||||
| Financing Activities |
||||||||
| Increase in bank indebtedness |
25,290 |
4,710 |
||||||
| Repayment of bank indebtedness |
(333) |
- |
||||||
| Issuance of subsidiary shares to non-controlling interests - private offering |
40,000 |
44,551 |
||||||
| Share issuance costs from the issuance of subsidiary shares to non-controlling |
||||||||
| interests - private offering |
(2,000) |
(3,556) |
||||||
| Issuance of subsidiary shares to non-controlling interests - public offering |
178,226 |
- |
||||||
| Share issuance expenses – public offering |
(16,257) |
- |
||||||
| Exercise of stock options |
35,609 |
10,834 |
||||||
| Treasury stock repurchased for settlement of share based compensation |
(10,000) |
(790) |
||||||
| Repurchase of common shares |
(34,276) |
(3,063) |
||||||
| Dividends paid to non-controlling interests |
(9,511) |
- |
||||||
| Credit facility amendment fees paid |
(1,533) |
(427) |
||||||
| Net cash provided by financing activities |
205,215 |
52,259 |
||||||
| Effects of exchange rate changes on cash |
842 |
(54) |
||||||
| Increase in cash and cash equivalents during year |
210,946 |
76,957 |
||||||
| Cash and cash equivalents, beginning of year |
106,503 |
29,546 |
||||||
| Cash and cash equivalents, end of year |
$ |
317,449 |
$ |
106,503 |
||||
| IMAX CORPORATION |
||||||||||||||
| SELECTED FINANCIAL DATA |
||||||||||||||
| In accordance with United States Generally Accepted Accounting Principles |
||||||||||||||
| (in thousands of U.S. dollars) |
||||||||||||||
| The Company has seven reportable segments identified by category of product sold or service provided: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production; and other. The IMAX systems segment includes the design, manufacture, sale or lease of IMAX theater projection system equipment. The theater system maintenance segment includes the maintenance of IMAX theater projection system equipment in the IMAX theater network. The joint revenue sharing arrangements segment includes the provision of IMAX theater projection system equipment to an exhibitor in exchange for a share of the box-office and concession revenues. The film production and IMAX DMR segment includes the production of films and the performance of film re-mastering services. The film distribution segment includes the distribution of films for which the Company has distribution rights. The film post-production segment provides film post-production and film print services. The other segment includes certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items. |
||||||||||||||
| Three Months |
Years Ended |
|||||||||||||
| Ended December 31, |
Ended December 31, |
|||||||||||||
| 2015 |
2014 |
2015 |
2014 |
|||||||||||
| Revenue |
||||||||||||||
| IMAX Theater Systems |
||||||||||||||
| IMAX Systems |
||||||||||||||
| Sales and sales-type leases |
$ |
33,011 |
$ |
33,246 |
$ |
86,935 |
$ |
58,875 |
||||||
| Ongoing rent, fees, and finance income |
4,485 |
3,845 |
15,193 |
14,117 |
||||||||||
| Other |
6,259 |
3,747 |
17,579 |
12,154 |
||||||||||
| 43,755 |
40,838 |
119,707 |
85,146 |
|||||||||||
| Theater System Maintenance |
9,599 |
8,658 |
36,944 |
34,042 |
||||||||||
| Joint Revenue Sharing Arrangements |
31,861 |
22,961 |
99,120 |
68,418 |
||||||||||
| Film |
||||||||||||||
| Production and IMAX DMR |
31,945 |
25,587 |
107,089 |
83,172 |
||||||||||
| Film distribution and post-production |
2,173 |
4,413 |
10,945 |
19,763 |
||||||||||
| 34,118 |
30,000 |
118,034 |
102,935 |
|||||||||||
| Total |
$ |
119,333 |
$ |
102,457 |
$ |
373,805 |
$ |
290,541 |
||||||
| Gross margins |
||||||||||||||
| IMAX Theater Systems |
||||||||||||||
| IMAX systems(1) |
||||||||||||||
| Sales and sales-type leases |
$ |
20,070 |
$ |
20,322 |
$ |
44,790 |
$ |
34,483 |
||||||
| Ongoing rent, fees, and finance income |
4,267 |
3,646 |
14,378 |
13,445 |
||||||||||
| Other |
700 |
331 |
279 |
129 |
||||||||||
| 25,037 |
24,299 |
59,447 |
48,057 |
|||||||||||
| Theater System Maintenance |
2,811 |
3,385 |
12,702 |
12,375 |
||||||||||
| Joint Revenue Sharing Arrangements(1) |
21,556 |
14,671 |
68,372 |
44,714 |
||||||||||
| Film |
||||||||||||||
| Production and IMAX DMR(1) |
22,003 |
19,745 |
77,645 |
62,922 |
||||||||||
| Film distribution and post-production(1) |
476 |
1,644 |
1,122 |
5,320 |
||||||||||
| 22,479 |
21,389 |
78,767 |
68,242 |
|||||||||||
| Total |
$ |
71,883 |
$ |
63,744 |
$ |
219,288 |
$ |
173,388 |
||||||
| __________________ |
||||||||||||||
| (1) |
IMAX systems include marketing and commission costs of $1.2 million and $3.0 million for the three and twelve months ended December 31, 2015, respectively (2014 - $1.5 million and $2.7 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $1.6 million and $4.3 million for the three and twelve months ended December 31, 2015, respectively (2014 - $1.1 million and $3.2 million, respectively). Production and DMR segment margins include marketing costs of $5.0 million and $13.3 million for the three and twelve months ended December 31, 2015, respectively (2014 - $1.8 million and $7.1 million, respectively). Distribution segment margins include marketing costs recovery of less than $0.1 million and recovery of $0.1 million for the three and twelve months ended December 31, 2015, respectively (2014 - $0.1 million recovery and $0.6 million expense, respectively). |
|||||||||||||
| IMAX CORPORATION |
|||||||||
| OTHER INFORMATION |
|||||||||
| (in thousands of U.S. dollars) |
|||||||||
| Non-GAAP Financial Measures: |
|||||||||
| In this release, the Company presents adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share as supplemental measures of performance of the Company, which are not recognized under U.S. GAAP. The Company presents adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) on net income. In addition, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share because it believes that they are important supplemental measures of its comparable financial results and could potentially distort the analysis of trends in business performance and it wants to ensure that its investors fully understand the impact of net income attributable to non-controlling interests and its stock-based compensation (net of any related tax impact) in determining net income attributable to common shareholders. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share should be considered in addition to, and not as a substitute for, net income and net income attributable to common shareholders and other measures of financial performance reported in accordance with U.S. GAAP. |
|||||||||
| The Credit Facility provides that the Company will be required at all times to satisfy a Minimum Liquidity Test (as defined in the Credit Agreement) of at least $50.0 million. The Company will also be required to maintain minimum EBITDA (as defined in the credit agreement) of $100.0 million. The Company must also maintain a Maximum Total Leverage Ratio (as defined in the credit agreement) of 2.25:1.0, which requirement decreases to (i) 2.0:1.0 on December 31, 2016; and (ii) 1.75:1.0 on December 31, 2017. The Company was in compliance with all of these requirements at December 31, 2015. The Maximum Total Leverage Ratio was 0.21:1 as at December 31, 2015, where Total Debt (as defined in the credit agreement) is the sum of all obligations evidenced by notes, bonds, debentures or similar instruments and was $29.7 million. EBITDA is calculated as follows: |
|||||||||
| Quarter Ended |
Year Ended |
Year Ended |
|||||||
| December 31, 2015 |
December 31, 2015(1) |
December 31, 2014 |
|||||||
| Net income |
$ |
26,245 |
$ |
64,624 |
$ |
42,169 |
|||
| Add (subtract): |
|||||||||
| Loss from equity accounted investments |
792 |
2,402 |
1,071 |
||||||
| Provision for income taxes |
7,644 |
20,052 |
14,683 |
||||||
| Interest expense, net of interest income |
250 |
693 |
519 |
||||||
| Depreciation and amortization, including film asset amortization |
11,259 |
41,787 |
33,230 |
||||||
| Write-downs, net of recoveries including asset impairments and receivable provisions |
797 |
3,725 |
5,294 |
||||||
| Stock and other non-cash compensation |
7,175 |
22,379 |
15,467 |
||||||
| EBITDA attributable to non-controlling interests(2) |
(6,015) |
(14,885) |
(3,937) |
||||||
| $ |
48,147 |
$ |
140,777 |
$ |
108,496 |
||||
| Revenues attributed to IMAX common shareholders |
$ |
106,981 |
$ |
347,862 |
$ |
283,001 |
|||
| Adjusted EBITDA margin |
45.0% |
40.5% |
38.3% |
||||||
| __________________ |
|||
| (1) |
Ratio of funded debt calculated using twelve months ended EBITDA. |
||
| (2) |
The EBITDA calculation specified for purpose of the minimum EBITDA covenant excludes the reduction in EBITDA from the Company's non-controlling interests. |
||
| IMAX CORPORATION |
||||||||||||||
| OTHER INFORMATION |
||||||||||||||
| (in thousands of U.S. dollars) |
||||||||||||||
| Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended December 31, 2015 vs. 2014: |
||||||||||||||
| The Company reported net income of $26.2 million or $0.38 per basic share and $0.37 per diluted share for the quarter ended December 31, 2015 as compared to net income of $22.5 million or $0.32 per basic and diluted share for the quarter ended December 31, 2014. Net income for the quarter ended December 31, 2015 includes a $6.9 million charge or $0.10 per diluted share (2014 — $3.8 million or $0.05 per diluted share) for stock-based compensation. Adjusted net income, which consists of net income excluding the impact of stock-based compensation and the related tax impact, was $31.7 million or $0.45 per diluted share for the quarter ended December 31, 2015 as compared to adjusted net income of $25.8 million or $0.36 per diluted share for the quarter ended December 31, 2014. Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation and the related tax impact, was $27.3 million or $0.39 per diluted share for the quarter ended December 31, 2015 as compared to adjusted net income attributable to common shareholders of $24.2 million or $0.34 per diluted share for the quarter ended December 31, 2014. A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measure, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below: |
||||||||||||||
| Quarter Ended December 31, |
||||||||||||||
| 2015 |
2014 |
|||||||||||||
| Net Income |
Diluted EPS |
Net Income |
Diluted EPS |
|||||||||||
| Reported net income |
$ |
26,245 |
$ |
0.37 |
(1) |
$ |
22,514 |
$ |
0.32 |
(1) |
||||
| Adjustments: |
||||||||||||||
| Stock-based compensation |
6,949 |
0.10 |
3,800 |
0.05 |
||||||||||
| Tax impact on items listed above |
(1,453) |
(0.02) |
(563) |
(0.01) |
||||||||||
| Adjusted net income |
31,741 |
0.45 |
(1) |
25,751 |
0.36 |
(1) |
||||||||
| Net income attributable to non-controlling interests |
(3,752) |
(0.05) |
(1,522) |
(0.02) |
||||||||||
| Stock-based compensation (net of tax) attributable to |
||||||||||||||
| non-controlling interests |
(703) |
(0.01) |
- |
- |
||||||||||
| Adjusted net income attributable to common shareholders |
$ |
27,286 |
$ |
0.39 |
(1) |
$ |
24,229 |
$ |
0.34 |
(1) |
||||
| Weighted average diluted shares outstanding |
70,764 |
69,958 |
||||||||||||
| _____________ |
||||||||||||||
| (1) |
Includes impact of less than $0.1 million (2014 - $0.1 million) of accretion charges associated with redeemable Class C shares of IMAX China. |
|||||||||||||
| Adjusted Net Income and Adjusted Diluted Per Share Calculations – Year Ended December 31, 2015 vs. 2014: |
||||||||||||||
| The Company reported net income of $64.6 million or $0.92 per basic share and $0.90 per diluted share for the year ended December 31, 2015 as compared to net income of $42.2 million or $0.61 per basic share and $0.59 per diluted share for the year ended December 31, 2014. Net income for the year ended December 31, 2015 includes a $21.9 million charge or $0.31 per diluted share (2014 — $15.1 million or $0.22 per diluted share) for stock-based compensation. Adjusted net income, which consists of net income excluding the impact of stock-based compensation and the related tax impact, was $82.4 million or $1.15 per diluted share for the year ended December 31, 2015 as compared to adjusted net income of $54.9 million or $0.78 per diluted share for the year ended December 31, 2014. Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation and the related tax impact, was $73.0 million or $1.02 per diluted share for the year ended December 31, 2015 as compared to adjusted net income attributable to common shareholders of $52.5 million or $0.75 per diluted share for the year ended December 31, 2014. A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measure, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below: |
||||||||||||||
| Year Ended December 31, |
||||||||||||||
| 2015 |
2014 |
|||||||||||||
| Net Income |
Diluted EPS |
Net Income |
Diluted EPS |
|||||||||||
| Reported net income |
$ |
64,624 |
$ |
0.90 |
(1) |
$ |
42,169 |
$ |
0.59 |
(1) |
||||
| Adjustments: |
||||||||||||||
| Stock-based compensation |
21,880 |
0.31 |
15,128 |
0.22 |
||||||||||
| Tax impact on items listed above |
(4,056) |
(0.06) |
(2,370) |
(0.03) |
||||||||||
| Adjusted net income |
82,448 |
1.15 |
(1) |
54,927 |
0.78 |
(1) |
||||||||
| Net income attributable to non-controlling interests |
(8,780) |
(0.12) |
(2,433) |
(0.03) |
||||||||||
| Stock-based compensation (net of tax) attributable to |
||||||||||||||
| non-controlling interests |
(703) |
(0.01) |
- |
- |
||||||||||
| Adjusted net income attributable to common shareholders |
$ |
72,965 |
$ |
1.02 |
(1) |
$ |
52,494 |
$ |
0.75 |
(1) |
||||
| Weighted average diluted shares outstanding |
71,058 |
69,754 |
||||||||||||
| _____________ |
||||||||||||||
| (1) |
Includes impact of $0.8 million (2014 - $0.4 million) of accretion charges associated with redeemable Class C shares of IMAX China. |
|||||||||||||
| Free Cash Flow: |
||||||
| Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company's after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below: |
||||||
| For the |
For the |
|||||
| 3 months ended |
12 months ended |
|||||
| December 31, 2015 |
December 31, 2015 |
|||||
| (In thousands of U.S. Dollars) |
||||||
| Net cash provided by operating activities |
$ |
41,885 |
$ |
83,685 |
||
| Net cash used in investing activities |
(13,762) |
(78,796) |
||||
| Free cash flow |
$ |
28,123 |
$ |
4,889 |
||
Logo - http://photos.prnewswire.com/prnh/20111107/MM01969LOGO
SOURCE IMAX Corporation
Share this article